Company Panacos Pharmaceuticals, Inc. Other OTC
Equities
PANC
US69811Q1067
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Anti-infective Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -36.62% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -36.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,640,136 | 53,640,136 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Panacos Pharmaceuticals, Inc.
134 Coolidge Avenue
02472, Watertown
+
Sector
1st Jan change | Capi. | |
---|---|---|
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |